Aaron Morris, PostEra CEO

Am­gen lines up new AI biotech part­ner in PostEra to de­vel­op small mol­e­cule med­i­cines

Am­gen is en­list­ing AI start­up PostEra for a drug dis­cov­ery deal for five small mol­e­cule pro­grams, PostEra an­nounced Thurs­day morn­ing.

Few de­tails about the col­lab­o­ra­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.